The average Wall Street price target implies a 113.3% upside for Avalo Therapeutics (AVTX) versus the current price. The piece highlights a positive trend in earnings estimate revisions that could support upside, but cautions the reliability of price-target averages. Monitor upcoming catalysts (clinical data, revisions) to see if estimates converge and validate the implied move.
The average Wall Street price target implies a 113.3% upside for Avalo Therapeutics (AVTX) versus the current price. The piece highlights a positive trend in earnings estimate revisions that could support upside, but cautions the reliability of price-target averages. Monitor upcoming catalysts (clinical data, revisions) to see if estimates converge and validate the implied move.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
